圣诺生物(688117)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688117 圣诺生物

已收盘 07-30 15:00:00

{"stockData":{"symbol":"688117","market":"SH","secType":"STK","nameCN":"圣诺生物","latestPrice":39.9,"timestamp":1753858800000,"preClose":42.12,"halted":0,"volume":9524796,"delay":0,"changeRate":-0.0527,"floatShares":157000000,"shares":157000000,"eps":0.5126,"marketStatus":"已收盘","change":-2.22,"latestTime":"07-30 15:00:00","open":40.5,"high":41.97,"low":39.9,"amount":388000000,"amplitude":0.0491,"askPrice":39.9,"askSize":47,"bidPrice":39.89,"bidSize":41,"shortable":0,"etf":0,"ttmEps":0.5126,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":5,"adr":0,"adjPreClose":42.12,"symbolType":"stock_kcb","openAndCloseTimeList":[[1753839000000,1753846200000],[1753851600000,1753858800000]],"highLimit":46.33,"lowLimit":37.91,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":157385978,"isCdr":false,"pbRate":6.5,"roa":"--","peRate":77.838471,"roe":"5.0%","epsLYR":0.45,"committee":0.021869,"marketValue":6280000000,"turnoverRate":0.0605,"status":1,"afterMarket":{"amount":0,"volume":0,"close":39.9,"buyVolume":0,"sellVolume":0,"time":1753860838019,"indexStatus":"已收盘 07-30 15:30:00","preClose":42.12},"floatMarketCap":6280000000},"requestUrl":"/m/hq/s/688117","defaultTab":"news","newsList":[{"id":"2555303018","title":"圣诺生物股价下跌5.01% 政策催化与资金分流致调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2555303018","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555303018?lang=zh_cn&edition=full","pubTime":"2025-07-30 14:53","pubTimestamp":1753858408,"startTime":"0","endTime":"0","summary":"圣诺生物股价大幅下跌，最新价40.01元，跌幅5.01%。多重因素共振引发股价波动圣诺生物短期波动受政策催化与市场风格切换双重影响。7月1日创新药产业政策落地后，单日主力资金净流入达3912万元，直接推动股价单日涨幅超6%。研发转化与估值重构主导后市长期看，圣诺生物的研发转化效率和全球化布局是核心变量。当前股价较年初已累计上涨119.4%，资金分歧加剧，后续或进入震荡分化阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730145331a46b00ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730145331a46b00ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2555962600","title":"医药研发外包CRO，谁是盈利最强企业？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555962600","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555962600?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:59","pubTimestamp":1753844349,"startTime":"0","endTime":"0","summary":"CRO又称“医药研发外包企业”，是指通过合同形式为医药企业在药物研发过程中提供专业化外包服务的公司或机构。医药研发外包CRO产业链企业盈利能力企业盈利能力通常表现为一定时期内企业收益数额的多少及其水平的高低。本文为企业价值系列之篇，共选取48家医药研发外包CRO产业链企业作为研究样本，并以净资产收益率、毛利率、净利率等为评价指标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073010591494c2dfe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073010591494c2dfe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","688117","03759","603456","688131","688621","688073","BK0216","603259","02359"],"gpt_icon":0},{"id":"2553235405","title":"圣诺生物(688117.SH)：醋酸加尼瑞克注射液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2553235405","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553235405?lang=zh_cn&edition=full","pubTime":"2025-07-22 17:02","pubTimestamp":1753174978,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣诺生物(688117.SH)发布公告，公司全资子公司成都圣诺生物制药有限公司于近日收到国家药品监督管理局(简称“国家药监局”)签发的关于醋酸加尼瑞克注射液的《药品注册证书》。醋酸加尼瑞克，在接受辅助生殖技术(ART)控制性卵巢刺激(COS)方案的妇女中使用，用于预防过早出现促黄体激素(LH)峰。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"圣诺生物(688117.SH)：醋酸加尼瑞克注射液获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2552690453","title":"CRO概念盘中跳水，圣诺生物跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552690453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552690453?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:48","pubTimestamp":1752803324,"startTime":"0","endTime":"0","summary":"07月18日，CRO概念盘中跳水，截至09点48分，CRO概念整体指数下跌1.08%，报528.040点。从个股上来看，该概念的成分股中，圣诺生物跌0.33%，凯莱英、皓元医药、毕得医药跌幅居前。从资金上来看，截止发稿，CRO概念主力净流入为-1.91亿，其中药明康德受到资金热捧，主力净流入6846.12万；拉长时间线来看，该板块近20日主力资金净流入-5.81亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094844a6b0e6a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094844a6b0e6a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0239","688117","BK0216"],"gpt_icon":0},{"id":"2552410627","title":"2025 年创新药企业中报业绩：6 家预增先锋的增长密码","url":"https://stock-news.laohu8.com/highlight/detail?id=2552410627","media":"新马投研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552410627?lang=zh_cn&edition=full","pubTime":"2025-07-17 15:01","pubTimestamp":1752735683,"startTime":"0","endTime":"0","summary":"从已披露的中报业绩预告来看，多家创新药及产业链企业净利润同比增幅显著，其中 6 家公司凭借差异化的业务布局与强劲的增长动能脱颖而出。截至 2025 年 1 月，已向美国合作方发货近 140 万支，国际业务占比跃升至 50% 以上。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717150936a6af1f21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717150936a6af1f21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600276","159992","603259","688117","BK0239"],"gpt_icon":0},{"id":"2551110783","title":"6家医药股中报业绩“全线飘红”，利润最高预增逾431%！","url":"https://stock-news.laohu8.com/highlight/detail?id=2551110783","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551110783?lang=zh_cn&edition=full","pubTime":"2025-07-16 15:01","pubTimestamp":1752649263,"startTime":"0","endTime":"0","summary":"截至当前，已有多家医药龙头抢先亮出半年度“成绩单”，预告盈利大幅攀升。名单包括：甘李药业、药明康德、圣诺生物、兄弟科技、沃华医药及美诺华等，均预计上半年归母净利润同比增幅超过100%，为板块注入久违的振奋剂。甘李药业业绩反转扣非净利润增长近3倍！最新估算显示，其2025年上半年归属于母公司股东的净利润约85.61亿元，同比增速已轻松越过100%大关。兄弟科技业绩“狂飙”净利预增四倍多！GLP-1订单接到手软圣诺生物业绩预增三倍！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716151018a44e0cb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716151018a44e0cb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","LU1997244956.HKD","603087","LU2495084118.USD","LU1969619763.USD","603538","LU1997245094.SGD","159938","603259","688117","BK0216","LU2488822045.USD","LU0456842615.SGD","LU1997245177.USD"],"gpt_icon":0},{"id":"2551112986","title":"圣诺生物涨5.13%创近4年新高 政策与资金共振推动股价上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2551112986","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551112986?lang=zh_cn&edition=full","pubTime":"2025-07-16 13:38","pubTimestamp":1752644288,"startTime":"0","endTime":"0","summary":"圣诺生物股价今日大幅上涨，截至13点37分，最新价报40.34元/股，上涨5.13%，创近4年新高，并成功突破40元整数关口。政策与资金共振下的价值重估圣诺生物近期净流入受政策与资金面双重驱动。7月1日创新药支持政策出台后，单日主力资金净流入达3912万元，推动股价单日涨幅超6%。研发转化与估值锚的再平衡长期看，圣诺生物的核心竞争力在于创新药研发转化及全球化布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133818a44de70e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133818a44de70e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2551117364","title":"减肥药概念盘中拉升，丽珠集团涨8.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551117364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551117364?lang=zh_cn&edition=full","pubTime":"2025-07-16 13:37","pubTimestamp":1752644264,"startTime":"0","endTime":"0","summary":"07月16日，减肥药概念盘中拉升，截至13点37分，减肥药概念整体指数上涨1.04%，报1160.590点。从个股上来看，该概念的成分股中，丽珠集团涨8.39%，圣诺生物涨幅超过5%。从资金上来看，截止发稿，减肥药概念主力净流入为6606.39万，其中复星医药受到资金热捧，主力净流入1.14亿；拉长时间线来看，该板块近20日主力资金净流入-50.83亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133744a44de6c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133744a44de6c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","000513","BK0188","BK0187","688117"],"gpt_icon":0},{"id":"2551592561","title":"新易盛“高歌猛进”、通威股份预亏超49亿元 川股半年报预告密集来袭","url":"https://stock-news.laohu8.com/highlight/detail?id=2551592561","media":"川观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551592561?lang=zh_cn&edition=full","pubTime":"2025-07-15 14:53","pubTimestamp":1752562380,"startTime":"0","endTime":"0","summary":"川观新闻记者 彭瑀珩进入7月中旬，四川上市公司2025年半年报业绩预告披露节奏加快。截至7月14日晚8时30分，据记者统计，已有53家川股对外披露上半年业绩预告。其中光伏龙头通威股份的业绩表现最受关注——公司预计上半年净利润为-52亿元至-49亿元，同比降幅达56.6%—66.19%，成为目前的川股业绩预告中亏损规模最大的公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715145416a6aa6e5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715145416a6aa6e5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0201","LU1781817850.SGD","BK0132","600331","BK0077","BK0183","LU1655091616.SGD","BK0238","603679","BK0276","SGXZ49509284.SGD","BK0224","BK0028","688117","BK0012","BK0167","BK0188","BK0214","BK0196","BK0148","603333","300502","600109","BK0044","BK0054","600438","SGXZ81163826.USD","LU1580142542.USD"],"gpt_icon":0},{"id":"2551137795","title":"CRO概念盘中跳水，圣诺生物跌1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551137795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551137795?lang=zh_cn&edition=full","pubTime":"2025-07-15 10:24","pubTimestamp":1752546263,"startTime":"0","endTime":"0","summary":"07月15日，CRO概念盘中跳水，截至10点24分，CRO概念整体指数下跌2.04%，报505.340点。从个股上来看，该概念的成分股中，圣诺生物跌1.13%，诺思格、药石科技、蔚蓝生物跌幅居前。从资金上来看，截止发稿，CRO概念主力净流入为-5.99亿，其中义翘神州受到资金热捧，主力净流入1515.23万；拉长时间线来看，该板块近20日主力资金净流入-31.15亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715102423a6a9f566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715102423a6a9f566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2551883181","title":"聚焦川股半年报预告丨7公司净利润翻番，华西证券盈利居首","url":"https://stock-news.laohu8.com/highlight/detail?id=2551883181","media":"金融投资报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551883181?lang=zh_cn&edition=full","pubTime":"2025-07-14 18:30","pubTimestamp":1752489028,"startTime":"0","endTime":"0","summary":"四川长虹：非经常性损益增长提振业绩除了上述3家上市公司半年度业绩大幅增长以外，四川省内还有4家上市公司业绩表现亮眼，净利润预计将实现翻番增长。2025年上半年，四川长虹预计将实现归属于母公司所有者的净利润为43900万元至57100万元，同比增加约56.53%至103.59%。归属于上市公司股东的净利润较上年同期预计涨幅较大，主要因非经常性损益显著增长，由被投资企业四川华丰科技股份有限公司公允价值增加引起。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714183506a449bce4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714183506a449bce4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600839","688117","002926"],"gpt_icon":0},{"id":"2551974686","title":"减肥药概念盘中拉升，圣诺生物涨8.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551974686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551974686?lang=zh_cn&edition=full","pubTime":"2025-07-14 14:27","pubTimestamp":1752474467,"startTime":"0","endTime":"0","summary":"07月14日，减肥药概念盘中拉升，截至14点27分，减肥药概念整体指数上涨1.02%，报1152.630点。从个股上来看，该概念的成分股中，圣诺生物涨8.86%，博瑞医药、泰恩康、皓元医药涨幅居前。从资金上来看，截止发稿，减肥药概念主力净流入为-9267.38万，其中恒瑞医药受到资金热捧，主力净流入2.31亿；拉长时间线来看，该板块近20日主力资金净流入-67.69亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071414274797a547f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071414274797a547f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0405327148.USD","LU1969619763.USD","LU1064130708.USD","600276","LU2148510915.USD","LU2495084118.USD","BK0196","BK0028","LU1328615791.USD","BK0060","BK0239","LU1997244956.HKD","LU0405327494.USD","BK0188","LU2328871848.SGD","LU2488822045.USD","BK0183","LU1064131003.USD","BK0012","LU1655091616.SGD","LU1997245094.SGD","LU1997245177.USD","688117"],"gpt_icon":0},{"id":"2551904135","title":"圣诺生物涨5.41% 政策催化与资金流入共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2551904135","media":"智选洞察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551904135?lang=zh_cn&edition=full","pubTime":"2025-07-14 14:21","pubTimestamp":1752474084,"startTime":"0","endTime":"0","summary":"圣诺生物股价今日大幅上涨，截至14点20分，最新价为36.99元/股，涨幅达5.41%。政策催化与资金共振圣诺生物近期股价波动与创新药政策及资金面变化紧密相关。7月1日创新药支持政策出台后，公司单日主力资金净流入达3912万元，推动股价单日涨幅超6%。创新壁垒与成长动能长期来看，圣诺生物的核心竞争力在于创新药研发转化能力及全球化布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714142125a6a7f632&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714142125a6a7f632&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2550641963","title":"2025中报前瞻：华银电力暂居预增王  AI、医药业绩爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2550641963","media":"21世纪经济报道","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550641963?lang=zh_cn&edition=full","pubTime":"2025-07-10 18:34","pubTimestamp":1752143657,"startTime":"0","endTime":"0","summary":"华银电力股价7月以来累计涨幅超过 76%。AI、医药业绩爆发从绝对值规模来看，截至7月9日晚公告，合计有85家企业预计归母净利润上限过亿，其中21 家企业超过10亿元。2025年上半年，公司多肽原料药业务表现较好，使业绩同比实现较大增长，净利润同比显著提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710183701a4426752&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710183701a4426752&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1979443071.USD","LU1580142542.USD","603086","SGXZ49509284.SGD","LU0051755006.USD","LU1655091616.SGD","601138","LU1781817850.SGD","LU2289578879.USD","159938","BK0188","BK0214","LU0456827905.SGD","688117","BK0271","SGXZ81163826.USD","LU1064131003.USD","BK0010","LU2148510915.USD","LU2495084118.USD","LU1997244956.HKD","LU1997245094.SGD","LU1934453819.USD","LU1997245177.USD","LU1064130708.USD","600744"],"gpt_icon":0},{"id":"2550554026","title":"半年报行情开启！业绩大幅预增名单出炉！","url":"https://stock-news.laohu8.com/highlight/detail?id=2550554026","media":"金融小博士","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550554026?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:00","pubTimestamp":1752069600,"startTime":"0","endTime":"0","summary":"随着 A 股半年报业绩预告密集披露，一批业绩大增股浮出水面，成为市场关注焦点。A 股半年度业绩预告披露密集期，超 120 家公司发布预告，近八成预增、略增等。此外，在 2024 年上半年低基数下，深深房 A、翔港科技等多家公司今年上半年业绩也预计翻倍增长 。年内股价涨幅超160%，成为市场焦点。亮点：上半年净利润同比增267%，毛利率提升至50.7%，受益于AIoT及汽车智能化需求爆发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709220140a69f98b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709220140a69f98b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600744","688117","601138","603799","02607","688591","601607","600111","688582","BK1197","603499","SHPMY"],"gpt_icon":0},{"id":"2550534651","title":"圣诺生物：中期业绩预增超300%背后，多肽龙头的价值逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2550534651","media":"CPHI制药在线","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550534651?lang=zh_cn&edition=full","pubTime":"2025-07-09 17:45","pubTimestamp":1752054334,"startTime":"0","endTime":"0","summary":"关注并星标CPHI制药在线当圣诺生物2025年中报业绩预告披露的那一刻，资本市场再次见证了多肽赛道的爆发力。2025年以来，圣诺生物的股价伴随着业绩预告的披露一度上涨超50%，但市场对多肽行业产能过剩的担忧又使其近期回调近20%。当投资者惊叹于圣诺生物半年报的业绩增幅时，更应穿透数据表象，看清其增长的底层逻辑。圣诺生物在近期的投资者交流中提到：\"GLP-1业务目前占比约30%，公司不会将所有鸡蛋放在一个篮子里。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709190103a440389e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709190103a440389e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2549516759","title":"上半年湘企华银电力预计净利润增长超3600%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549516759","media":"长沙晚报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549516759?lang=zh_cn&edition=full","pubTime":"2025-07-08 16:10","pubTimestamp":1751962215,"startTime":"0","endTime":"0","summary":"目前，净利润增长最高的是湘企华银电力，增长幅度达3600.7%～4423.07%。翰宇药业预告显示，公司预计上半年实现归母净利润1.42亿元至1.62亿元，同比增长1470.82%至1663.89%。圣诺生物预计2025年半年度实现归属于母公司所有者的净利润7702.75万元至9414.48万元，同比增长253.54%至332.10%。工业富联8日发布公告称，预计2025年上半年实现归母净利润119.58亿元至121.58亿元，同比上升36.84%至39.12%。从净利润预增幅度中值来看，湘企华银电力的净利润同比增幅最高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708161236a43d8e0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708161236a43d8e0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600744","601138","688117"],"gpt_icon":0},{"id":"2549564892","title":"25家公司半年业绩倍增，工业富联云计算业务收入增超50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549564892","media":"粤股8","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549564892?lang=zh_cn&edition=full","pubTime":"2025-07-08 08:27","pubTimestamp":1751934452,"startTime":"0","endTime":"0","summary":"25公司预计半年业绩倍增7月7日晚，工业富联发布的2025年半年度业绩预告显示，公司预计上半年实现归属于母公司所有者的净利润119.58亿元至121.58亿元，同比增长36.84%至39.12%。工业富联表示，公司云计算业务在第二季度实现高速增长，整体板块营业收入较去年同期增长超过50%。在半导体领域，泰凌微、芯动联科、芯朋微、瑞芯微等公司预计上半年归母净利润同比增幅均超过100%，长川科技预增幅度超过60%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708083247a69bd517&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708083247a69bd517&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997244956.HKD","LU0051755006.USD","601138","LU1064131003.USD","LU1781817850.SGD","BK0010","LU1655091616.SGD","BK0172","BK0196","BK0214","LU1934453819.USD","SGXZ81163826.USD","BK0188","LU1997245177.USD","BK0088","LU2495084118.USD","SGXZ49509284.SGD","LU2148510915.USD","LU1979443071.USD","BK0005","LU1064130708.USD","BK0279","BK0183","BK0187","600482","LU2289578879.USD","LU1580142542.USD","688117","LU0456827905.SGD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2549655475","title":"【逾20家公司预计上半年盈利倍增 多个行业频发捷报】随着半年度业绩预告披露窗口期的开启，上市公司2025年上半年业绩成为市场关注的焦点。Wind数据显示，截至7月7日21时，A股已有78家上市公司发布2025年半年度业绩预告。其中，业绩“预喜”（包含预增、略增、扭亏）公司占比约七成，圣诺生物、川金诺等25家公司上半年归母净利润的预增幅度上限超过1倍。梳理发现，业绩“预喜”公司大多来自电子、基础化工、汽车、医药生物等行业领域。","url":"https://stock-news.laohu8.com/highlight/detail?id=2549655475","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549655475?lang=zh_cn&edition=full","pubTime":"2025-07-08 06:39","pubTimestamp":1751927960,"startTime":"0","endTime":"0","summary":"随着半年度业绩预告披露窗口期的开启，上市公司2025年上半年业绩成为市场关注的焦点。Wind数据显示，截至7月7日21时，A股已有78家上市公司发布2025年半年度业绩预告。其中，业绩“预喜”（包含预增、略增、扭亏）公司占比约七成，圣诺生物、川金诺等25家公司上半年归母净利润的预增幅度上限超过1倍。梳理发现，业绩“预喜”公司大多来自电子、基础化工、汽车、医药生物等行业领域。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/08063951540374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000808.SH","163118","688117","159982","300505","399300"],"gpt_icon":0},{"id":"2549308470","title":"创新药概念异动拉升 广生堂、微芯生物涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549308470","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549308470?lang=zh_cn&edition=full","pubTime":"2025-07-07 09:44","pubTimestamp":1751852651,"startTime":"0","endTime":"0","summary":"人民财讯7月7日电，创新药概念异动拉升，广生堂、微芯生物涨超10%，前沿生物、华纳药厂、泽璟制药、圣诺生物等股纷纷拉升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707094412a43ab2d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707094412a43ab2d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","688117","688799","688221","688321","300436","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753914166858,"stockEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":0.1857},{"period":"3month","weight":0.9086},{"period":"6month","weight":1.2773},{"period":"1year","weight":1.7128},{"period":"ytd","weight":1.1824}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0497},{"period":"3month","weight":0.1027},{"period":"6month","weight":0.1123},{"period":"1year","weight":0.2558},{"period":"ytd","weight":0.0788}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都圣诺生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7374人(较上一季度增加16.22%)","perCapita":"21343股","listingDate":"2021-06-03","address":"四川省成都市大邑县晋原镇工业大道一段(工业集中发展区内)","registeredCapital":"15738万元","survey":"　　成都圣诺生物科技股份有限公司的主营业务是多肽原料药和制剂产品的研发、生产与销售，同时提供多肽创新药药学研究服务、多肽类产品定制生产服务以及左西孟旦制剂代加工和左西孟旦原料药生产与出口。公司的主要产品是多肽创新药CDMO服务。","listedPrice":17.9},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣诺生物(688117)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣诺生物(688117)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣诺生物,688117,圣诺生物股票,圣诺生物股票老虎,圣诺生物股票老虎国际,圣诺生物行情,圣诺生物股票行情,圣诺生物股价,圣诺生物股市,圣诺生物股票价格,圣诺生物股票交易,圣诺生物股票购买,圣诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣诺生物(688117)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣诺生物(688117)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}